Luis Porrata HeadshotPrincipal Investigator: Dr. Luis Porrata

Disease: Non-Hodgkin Lymphoma

Research Description: Dr. Porrata’s clinical trial sought to improve the existing autologous stem cell transplant (ASCT) protocol used to treat non-Hodgkin's lymphoma patients. The existing method involved removing healthy blood cells from a patient, treating the patient with chemotherapy and then re-injecting the patient with their removed cells to regenerate a healthy blood system. By simply increasing both the total amount of cells and the relative amount of a specific cell type (natural killer cells) that are harvested and re-injected, the success rate of the procedure is increased. For almost no cost or additional risk, the rate of durable remissions seen in patients can increase from 50% to 70%. These protocol improvements can save lives and reduce healthcare costs for patients who suffer from a variety of blood cancers. Almost 600,000 ASCTs are performed around the world each year. This success could save up to 180,000 lives per year!

CWR funding role: Participating funder

Publication:  Biology of Blood and Marrow Transplantation

Since publication:

→ Data are supporting a change in clinical practice

→ Data are supporting trials in other diseases using the same repurposing treatment

Sign up for our eNewsletter today!


First Name

Cures Within Reach

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Wednesday the 21st. Copyright 2018 Cures Within Reach.